{"schema_version":"secwatch.filing_event.v1","accession":"0000950170-23-051141","form_type":"8-K","ticker":"REVB","cik":"0001810560","company_name":"REVELATION BIOSCIENCES, INC.","filed_at":"2023-10-02T23:59:59+00:00","discovered_at":"2026-05-14T18:03:30.583512+00:00","generated_at":"2026-06-10T06:28:58.820032+00:00","sec_items":["5.02","7.01","9.01"],"event_type":"leadership","sentiment":"neutral","materiality_score":0.55,"calibrated_materiality_score":0.55,"confidence":"high","headline":"Revelation Biosciences appoints Lakhmir Chawla to board; Curt LaBelle resigns","bullets":["Curt LaBelle M.D. resigned from Board on Sept 27, 2023, not due to any disagreements.","Lakhmir Chawla M.D. appointed as Class C director to fill vacancy, effective same date.","Dr. Chawla is CEO of Stavro Medical; former CMO at Silver Creek Pharma and La Jolla Pharmaceutical.","He will serve on Compensation and Nominations & Corporate Governance Committees.","No transactions requiring Item 404(a) disclosure between Dr. Chawla and the company."],"urls":{"canonical":"https://secwatch.observer/filing/0000950170-23-051141","json":"https://secwatch.observer/filing/0000950170-23-051141.json","markdown":"https://secwatch.observer/filing/0000950170-23-051141.md","text":"https://secwatch.observer/filing/0000950170-23-051141.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1810560/000095017023051141/0000950170-23-051141-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1810560/000095017023051141/revb-20230927.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-06-10T06:28:58.820032+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[{"claim_id":"e98f716608","claim":"Lakhmir Chawla was elected as Director at REVELATION BIOSCIENCES, INC..","evidence_excerpt":"On September 27, 2023, the Board of Directors elected Lakhmir Chawla M.D. (age 53) to the Board of Directors, as a Class C Director to fill the vacancy created by the resignation of Dr. La Belle.","evidence_source":"SEC 8-K Item 5.02","evidence_url":"https://www.sec.gov/Archives/edgar/data/1810560/000095017023051141/0000950170-23-051141-index.htm","confidence":0.95,"family_label":"Executive change","details":[{"label":"Action","value":"elected"},{"label":"Role","value":"Director"}],"fact_type":"executive_change"},{"claim_id":"ef581a1419","claim":"Curt LaBelle resigned as Director at REVELATION BIOSCIENCES, INC..","evidence_excerpt":"On September 27, 2023, Curt LaBelle, M.D., resigned from the Board of Directors of Revelation Biosciences, Inc. (the \"Company\").","evidence_source":"SEC 8-K Item 5.02","evidence_url":"https://www.sec.gov/Archives/edgar/data/1810560/000095017023051141/0000950170-23-051141-index.htm","confidence":0.95,"family_label":"Executive change","details":[{"label":"Action","value":"resigned"},{"label":"Role","value":"Director"}],"fact_type":"executive_change"}],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}